Yearly Publication Trends - cancer immunotherapy

Year	Publication Count
2024	4342
2023	12298
2022	6927
2021	5302
2020	3704
2019	1821
2018	1374
2017	1139
2016	1384
2015	738
2014	635

Relevant Publications

BRAF mutational status is associated with survival outcomes in locally advanced resectable and metastatic NSCLC.

Issue Release: 2024

Neoadjuvant Immunotherapy Effectiveness in Patients With Microsatellite Instability-High (MSI-H) Gastric Cancer.

Issue Release: 2024

Binding of interleukin-1 receptor antagonist to cholinergic receptor muscarinic 4 promotes immunosuppression and neuroendocrine differentiation in prostate cancer.

Issue Release: 2024

Organoids in gastrointestinal diseases: from bench to clinic.

Issue Release: 2024

Microbiome-driven anticancer therapy: A step forward from natural products.

Issue Release: 2024

HLA investigation in ICI-induced T1D and isolated ACTH deficiency including meta-analysis.

Issue Release: 2024

The immune microenvironment of lung adenocarcinoma featured with ground-glass nodules.

Issue Release: 2024

Light-Activated In Situ Vaccine with Enhanced Cytotoxic T Lymphocyte Infiltration and Function for Potent Cancer Immunotherapy.

Issue Release: 2024

Tissue-resident memory CD103+CD8+ T cells in colorectal cancer: its implication as a prognostic and predictive liver metastasis biomarker.

Issue Release: 2024

Mapping the landscape: a bibliometric study of global chimeric antigen receptor T cell immunotherapy research.

Issue Release: 2024

Identification and validation of tumor-specific T cell receptors from tumor infiltrating lymphocytes using tumor organoid co-cultures.

Issue Release: 2024

Systemic Therapy for Non-Melanoma Skin Cancers: Latest Advances.

Issue Release: 2024

Blood-based molecular and cellular biomarkers of early response to neoadjuvant PD-1 blockade in patients with non-small cell lung cancer.

Issue Release: 2024

NKG2A genetic deletion promotes human primary NK cell anti-tumor responses better than an anti-NKG2A monoclonal antibody.

Issue Release: 2024

Mesenteric Panniculitis as a Side Effect of Nivolumab in a Patient with Larnyngeal Cancer.

Issue Release: 2024

Targeting tumor-associated macrophage with mannosylated nanotherapeutics delivering TLR7/8 agonist enhances cancer immunotherapy.

Issue Release: 2024

Navigating through novelties concerning mCRC treatment-the role of immunotherapy, chemotherapy, and targeted therapy in mCRC.

Issue Release: 2024

Impact of high-salt diet in health and diseases and its role in pursuit of cancer immunotherapy by modulating gut microbiome.

Issue Release: 2024

Efficacy of nimotuzumab in combination with immunotherapy for a young recurrent cervical cancer patient: a case report and literature review.

Issue Release: 2024

From Genotype to Phenotype: Raman Spectroscopy and Machine Learning for Label-Free Single-Cell Analysis.

Issue Release: 2024

What is Uniform Particle Size?

What About Security Concerns?

What is the Future Scope of Nanotechnology in Electronics?

What are Lab-on-a-Chip Devices?

Why is Al2O3 Important in Nanotechnology?

Can you give an example of a significant Nanotechnology study published in PLOS ONE?

What is Informed Consent in Nanotechnology?

What Techniques are Used to Study Electron-Phonon Interaction?

How do Quantum Dot Solar Cells Work?

How Do Nanodevices Enhance Environmental Protection?

Partnered Content Networks

Relevant Topics